Thomas Hudson


Thomas Hudson

Thomas Hudson

Dr. Thomas J. Hudson is President and Scientific Director of the Ontario Institute for Cancer Research (OICR), which focuses on translational research in prevention, detection, diagnosis and treatment of cancer. Dr. Hudson is a thought leader in making personalized medicine a reality.

Since its inception, OICR has launched several large-scale programs including the Ontario Health Study, Smarter Imaging Program, Cancer Stem Cell Program, Pancreatic Cancer Genome Project (which is part of the International Cancer Genome Consortium), Innovation in Target Validation Program and High Impact Clinical Trials.

Dr. Hudson is internationally renowned for his work in genomics and human genome variation. Past positions include leadership roles as Director of the McGill University and Genome Quebec Innovation Centre and Assistant-Director of the Whitehead/MIT Center for Genome Research, where he led a team that generated physical and gene maps of the human and mouse genomes. Dr. Hudson has been a founding member of the International Haplotype Map Consortium and the Public Population Project in Genomics (P3G). He was instrumental in the creation of the International Cancer Genome Consortium and is the Chair of the Consortium’s Executive and Scientific Steering Committees.

Dr. Hudson is a member of the Steering Committee of the Global Alliance to Enable the Responsible Sharing of Data and is a co-author of the White Paper produced by the Alliance which details the purpose and benefits of establishing an international framework to allow genetic and clinical data to be collected, managed and shared in an effective, responsible, interpretive manner.

Dr. Hudson's laboratory at OICR is involved in the study of genome variation that affects cancer predisposition, progression, and response to therapy. His main project focuses on the genetic architecture of loci associated with risk of colorectal cancer.

In 2007, Dr. Hudson was appointed to the rank of Professor in the Departments of Molecular Genetics and Medical Biophysics at the University of Toronto. Dr. Hudson is a fellow of the Royal Society of Canada and an Officer of the Order of Canada. He is editor-in-chief of the journal Human Genetics and has co-authored more than 250 peer-reviewed scientific publications.


  • VP, Head of Oncology Discovery and Early Development, AbbVie, Redwood City, United States